Douglas Corley to Proton Pump Inhibitors
This is a "connection" page, showing publications Douglas Corley has written about Proton Pump Inhibitors.
Connection Strength
4.274
-
Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population. Am J Gastroenterol. 2020 05; 115(5):706-715.
Score: 0.698
-
Safety and Complications of Long-Term Proton Pump Inhibitor Therapy: Getting Closer to the Truth. Gastroenterology. 2019 09; 157(3):604-607.
Score: 0.663
-
Proton Pump Inhibitor and Histamine-2 Receptor Antagonist Use and Iron Deficiency. Gastroenterology. 2017 03; 152(4):821-829.e1.
Score: 0.550
-
Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors. Aliment Pharmacol Ther. 2016 Jan; 43(1):73-82.
Score: 0.512
-
Gastric acid-inhibiting medications and vitamin B12 deficiency--reply. JAMA. 2014 Apr 09; 311(14):1445-6.
Score: 0.459
-
Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013 Dec 11; 310(22):2435-42.
Score: 0.448
-
Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology. 2010 Jul; 139(1):93-101.
Score: 0.347
-
Chemoprevention in Barrett's esophagus: are we there yet, are we there yet...? Clin Gastroenterol Hepatol. 2009 Dec; 7(12):1266-8.
Score: 0.334
-
Will a Proton Pump Inhibitor and an Aspirin Keep the Doctor Away for Patients With Barrett's Esophagus? Gastroenterology. 2019 04; 156(5):1228-1231.
Score: 0.161
-
A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology. 2012 Oct; 143(4):917-26.e1.
Score: 0.102